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Role 
Cholangiocarcinoma 
of Percutaneous Transhepatic Cholangiography in 
Determination of Resectability 
RICHARD B. LYNN, MD, JOANNE A.P. WILSON, MD, and KYUNG J. CHO, MD 
Exploratory laparotomy is frequently used to diagnose, treat, or palliate cholangi- 
ocarcinoma although surgery is rarely curative. In light of newly developed percutaneous 
and endoscopic approaches to diagnosis and therapy, we reviewed our experience with 35 
cases of cholangiocarcinoma diagnosed and treated at the University of Michigan 
Medical Center from 1979 to 1984. Percutaneous transhepatic cholangiography (PTCA) 
was performed in 34 cases of which only four were resectable. All 22 patients who had 
preoperative cholangiograms suggesting unresectability had confirmation of this at 
surgery. Surgical palliation was accomplished with a combination of internal and 
percutaneous drainage in most cases. Angiographic, cytologic, and laboratory data are 
presented. PTCA accurately predicted unresectability of cholangiocarcinoma and is 
superior to angiography in this respect. In patients with cholangiocarcinoma, percutane- 
ous and endoscopic approaches offer alternatives to surgery for diagnosis and palliation. 
KEY WORDS: transhepatic cholangiography; cholangiocarcinoma obstructive jaundice; angiography; biliary 
cytology; biliary drainage; hypoalbuminemia. 
Cholangiocarcinoma is the third most common 
cause of malignant biliary obstruction, exceeded 
only by carcinomas of the pancreas and gallbladder. 
Cholelithiasis, choledocholithiasis, and ulcerative 
colitis have been associated with increased risk of 
cholangiocarcinoma. Obstructive jaundice is the 
most common presentation. Since this carcinoma 
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typically invades local tissues early, most are not 
resectable even at presentation, although only 20% 
metastasize within the liver and to distant sites 
(1--4). 
Visualization of the biliary tree is the pivotal step 
in the initial evaluation of obstructive jaundice and 
possible cholangiocarcinoma. Percutaneous trans- 
hepatic cholangiography (PTCA), has a success rate 
approaching 100% with bile duct dilatation, can 
assess the location and extent of biliary tract in- 
volvement, and has been proposed as a basis for 
determining surgical resectability (5-9). 
Surgical excision with adequate surgical margins 
remains the optimal therapy and the only chance of 
cure; however, since the tumor is often unresect- 
able at presentation, palliative drainage must be 
employed (10-18). Indications for surgery are the 
need for histologic diagnosis, curative resection, 
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TABLE 1. CHOLANGIOCARCINOMA: CHOLANGIOGRAPHY, ANGIOGRAPHY, AND SURGICAL RESECTABILITY AND PALLIATION 
Cholangiographic patterns 
Type H, right and left Type II1, common 
Type I, hepatic ducts, bifurcation hepatic and common 
Total intrahepatic and and proximal 1 cm of  bile ducts excluding 
cases segmental ducts common hepatic duct ampulla o f  Vater 
Cholangiographic extent of disease 34 
Angiograms*/evidence of 27/13 
unresectability 
Percutaneous drainage/internal 22/16 
drainage accomplished 
Exploratory laparotomyt/unresectable 26/24 
disease found 
Postop drainage external/internal/both 1/6/16 
5 25 4 
4/2 18/11 4/0 
4/3 14/11 4/2 
4/4 17/17 4/3 
0/1/3 1/3/13 0/2/1 
*One patient had an angiogram without cholangiogram. 
#Curative resections: one had type III cholangiogram, the other did not have a cholangiogram. 
and palliative drainage. Histologic diagnosis may 
also be achieved by cytologic examination of biliary 
fluid in up to 50% of cases (10, 19). Palliative 
drainage usually done at the time of PTCA can be 
maintained for short- or long-term drainage (20-35). 
This study reviews our experience with cholangi- 
ocarcinoma in light of these newly developed per- 
cutaneous methods of cholangiography, cytologic 
diagnosis, and palliative drainage. We assess the 
role of PTCA in the determination of tumor resect- 
ability in comparison with angiography and surgical 
findings. 
MATERIALS AND METHODS 
We retrospectively reviewed all patients with the diag- 
nosis of cholangiocarcinoma who presented to the Uni- 
versity of Michigan Medical Center between May 1979 
and July 1984 for definitive diagnostic evaluation and 
therapy. Thirty-five cases were identified, 29 of which 
had cytologic, surgical tissue, or autopsy confirmation of 
the diagnosis. The other six patients had cholangiograms 
and clinical courses compatible with cholangiocarcinoma. 
Cholangiograms as originally reported were classified 
according to the most proximal extent of the tumor: Group 
I had tumor in the intrahepatic and segmental ducts; group 
II involved the proximal extrahepatic ducts including the 
fight and left hepatic ducts, the bifurcation and proximal 1 
cm of the common hepatic duct; and group III included 
tumors limited to the distal extrahepatic ducts including the 
common hepatic duct and the common bile duct, excluding 
tumors of the ampulla of Vater. 
Survival as of December 1985 was determined either 
from the chart, tumor registry records, or telephone 
communication with the patient's relatives. 
RESULTS 
The median age of the patients was 64 years; 
patients were 20 men and 15 women. None had 
ulcerative colitis or sclerosing cholangitis, but a 
history of choledocholithiasis was reported in five 
patients. The chief complaints at presentation were 
jaundice in two thirds of the patients, and weight 
loss and abdominal pain in the remainder. The 
duration of symptoms prior to initial presentation 
was a median of one month with a range of two 
weeks to two years. Eleven patients had surgical 
intervention for their disease prior to transfer. Of 
these, only two had a histologic diagnosis. The 
mean bilirubin on admission was 16.1 mg/dl, and in 
three cases the bilirubin was less than 3.0 mg/dl. 
Reports of biliary ultrasonography were available in 
22 cases: 19 patients had dilated bile ducts and three 
reported no dilated ducts; two of these three were 
confirmed not to have dilated ducts by PTCA. 
PTCA was generally the next step in the diagnos- 
tic work-up (Table 1). Thirty-four of 35 patients had 
cholangiography. Five had type I or intrahepatic 
involvement. Twenty-five had type II or proximal 
extrahepatic duct involvement; 19 of these had 
tumor involving both the right and left hepatic 
ducts, while six had tumor only at the bifurcation 
and proximal common hepatic duct. Four patients 
had tumor only in the distal extrahepatic ducts. 
At the time of PTCA, percutaneous drainage was 
attempted in 22 patients with a 100% success rate. 
Sixteen patients had internal and external drainage 
and six patients had external drainage only. The 
mean duration of preoperative percutaneous drain- 
age was eight days. During this period, the bilirubin 
fell from 14.5 mg/dl to 9.8 mg/dl (P > 0.05). For 19 
patients where data were available, the albumin fell 
from 3.4 g/dl on admission to 3.0 g/dl preoperatively 
(P < 0.01). As acontrol for rehydration during this 
period, we found that the BUN decreased mini- 
mally from 15.8 mg/dl to 15.5 mg/dl (P > 0.05). 
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TABLE 2. CYTOLOGIC DIAGNOSIS 
Total Suspicious/ 
studied Negative positive 
Biliary fluid 18 14 4 
Positive surgical Bx* 13 2 
Percutaneous aspirate 8 6 2 
Positive surgical Bx 3 1 
Brushings 2 2 0 
Positive surgical Bx 2 0 
*Bx: biopsy. 
Cytologic specimens were obtained from 20 pa- 
tients (Table 2). Biliary sampling was suspicious or 
positive in only 22% (4/18 samples obtained), and 
percutaneous needle aspirate was positive in 25% 
with only eight samples studied. Angiography was 
done in 27 of 35 patients. Evidence of tumor unre- 
sectability such as portal vein encasement, extrahe- 
patic artery encasement, or distant liver metastasis 
(38-41) was reported in 13 of 27 cases. 
Exploratory laparotomy was performed in 26 of 
35 patients. Only two patients had attempted cura- 
tive resection of their tumors. These two patients 
were clearly distinguished from the rest of our 
population. The first had a large liver mass in the 
right lobe that angiography reported as a resectable 
hepatoma. The patient underwent right lobectomy 
and, on pathology, adenocarcinoma of bile duct 
origin was found. This patient had a recurrence of 
this tumor in the left lobe and died of his disease 28 
months after presentation. The second patient had 
carcinoma of the distal common bile duct. Cholan- 
giography and angiography found no evidence of 
unresectability, and she underwent a Whipple pro- 
cedure. She subsequently did poorly with much 
weight loss and died of sepsis at 13 months after 
surgery. There was no evidence of recurrence. 
In the remaining 24 patients undergoing surgery, 
unresectable disease was found. Patients were con- 
sidered unresectable because of lymph node involve- 
ment in six cases, vascular involvement (bilateral 
hepatic artery or portal vein) in four cases, bilateral 
ductal involvement in five cases, and extensive 
intrahepatic spread in eight cases. Biopsies were 
taken and a drainage procedure was done. Only one 
patient had internal drainage such as a Roux-en-Y 
hepatojejunostomy without a percutaneous tube, six 
had internal drainage in addition to a percutaneous 
tube, while 16 patients had external drainage via 
varying percutaneous drainage tubes. Nine patients 
had no surgery: one declined surgery; the other eight 
were felt to have unresectable disease, and the deci- 
sion was made not to attempt surgical palliation. 
Exploratory laparotomy with biopsy provided 
tissue diagnostic for cancer in 16 of the 20 patients 
who had negative preoperative cytology or previous 
surgical biopsy. Overall four of 26 cases had surgi- 
cal biopsies negative for cancer but were presumed 
to have the disease based on clinical and radiologic 
assessment and were treated accordingly. A surgi- 
cal mortality of 4% was noted. 
Complications of PTCA included fever >101 ~ F 
in four patients. Death might have been related to 
complications in two additional patients. One had a 
low-grade fever on the day of PTCA, then a fever 
with positive blood cultures 11 days after PTCA, 
and died of sepsis one week later. The second had a 
subphrenic abscess thought to be an infected hema- 
toma. This required surgical drainage, and the pa- 
tient died two months after presentation. 
Survival data were calculated based on known 
data of death in 31 of 35 patients. Two patients were 
still alive at the time of study. Two patients were 
lost to follow-up. Overall survival was 12.2 months. 
For patients who had surgery, the mean survival 
was 14.7 months, while those who did not have 
surgery had a mean survival of <1 month. The 
longest survivor is still alive at 61 months without 
evidence of recurrence. 
DISCUSSION 
Using cholangiographic locations of type I and II 
as evidence of unresectability, we find that all 22 
patients with preoperative cholangiograms suggest- 
ing unresectability had confirmation of this at sur- 
gery. The surgical findings in our series always 
reported tumor as or more extensive than that 
demonstrated by cholangiography. Although the 
surgical extent of disease frequently was not pre- 
cisely recorded, proximal extent of intraductal 
spread was generally the reason for unresectability. 
All 13 patients with evidence of unresectable dis- 
ease demonstrated by angiography also had type I 
or II cholangiographic findings. 
In the series of Nichols et al (6), of 69 patients 
with cholangiograms showing type I or II disease, 
only one patient had a possible surgical cure. In 
other series (10-18), many patients with type II 
disease underwent curative resections and their 
survival was about 17 months. Few if any had 
long-term survival. A recent series by Lai et al (42) 
found that even with aggressive curative resection 
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in 29 patients, the mean survival was 11.8 months 
with only one long-term survivor. 
Histologic diagnosis by surgical biopsy can be 
difficult, with frequent false negatives. This is due 
to the scarring around the tumor and the patchy 
nature of the disease. Nonoperative histologic diag- 
nosis can be made by a variety of percutaneous 
methods such as biliary fluid samples and needle 
aspiration of tumor. Harrell et al report positive 
cytology in 50% of biliary samples (19). Our findings 
are less than their results, with only 20% reported 
as positive or suspicious. Review of these speci- 
mens reveals many inadequate samples, typically 
with few or no epithelial cells. At our institution, 
much attention is currently being given to improv- 
ing these cytologic results. Radiologists are being 
more aggressive in their efforts at washings and 
brushings during PTCA and obtaining multiple sam- 
ples. A senior cytology staff physician currently 
prepares and reviews the specimens at the site in 
other radiologic diagnostic procedures. Naylor (un- 
published data) reports a twofold increase in posi- 
tive results since this practice was initiated. Appli- 
cation of these methods to biliary radiology could 
improve diagnostic cytologic yield. 
Palliative drainage was generally achieved by a 
combination of percutaneous and surgically placed 
tubes in the patient undergoing surgery. In either 
case, external drainage in addition to internal drain- 
age remained in place in most patients. External 
drainage is presumed to add an increased risk of 
infection but has the advantage of easy flushing or 
replacement if there is obstruction. It is not yet 
known how surgical and percutaneous placement of 
chronic drainage catheters would compare on a 
prospective basis. 
Our finding of a fall in albumin during the period 
of preoperative percutaneous drainage has not been 
reported previously. It is presumably due to a 
combination of poor nutrition and external drainage 
of copious proteinaceous biliary fluid. This may be 
of clinical significance in light of reports that albu- 
min is an independent predictor of poor prognosis 
(43-46). Emphasis needs to be placed on nutrition 
during this critical period, since protein needs may 
be additionally increased by biliary losses. While 
our study did not show a significant decrease in 
bilirubin during the period of percutaneous drain- 
age, a previous study on an overlapping population 
did show a significant decrease (37). 
Survival was lower in our group treated without 
surgery. This probably reflects the selection of this 
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group as poor surgical risk and thus poorer progno- 
sis. All of the patients fit the criteria of Bonnel et al 
for poor operative risk (43). 
Despite the generally high surgical risk of patients 
with cholangiocarcinoma, surgery is still frequently 
employed for assessment of extent of disease, tis- 
sue diagnosis, and palliative drainage. Percutane- 
ous transhepatic cholangiography can reliably pre- 
dict unresectability of cholangiocarcinoma. Ad- 
vances in percutaneous methods of cytologic diag- 
nosis and endoscopic and percutaneous techniques 
for palliative drainage offer alternatives to surgery. 
Utilization of endoscopic management of malignant 
biliary strictures has progressed recently. Palliation 
of biliary strictures, including hilar lesions, can be 
accomplished by the placement of biliary stents up 
to approximately 12 Fr with high rates of success 
and low mortality (47, 48). Percutaneous biliary 
drainage techniques including stent placement were 
introduced prior to endoscopic modalities and are 
used for chronic drainage; however, some studies 
suggest greater success, lower morbidity, and 
greater patient tolerance with endoscopic biliary 
prothesthetic drainage (49). 
Prospective studies are needed to compare surgi- 
cal and nonsurgical approaches to palliation in the 
hope of improving the morbidity and poor prognosis 
of this uncommon disease. 
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